Cannasouth

Cannasouth is a biopharmaceutical research and development company based in Waikato, New Zealand. The company has been established to focus on the commercial development of the medicinally beneficial attributes of cannabinoid compounds such as CBD, THC and associated chemical structures that are produced by the cannabis plant. The goal is the development of next-generation cannabinoid medicines that support patients' health outcomes and improve quality of life. Cannasouth products will be produced under GMP & ISO using environmentally friendly methods without the use of harmful chemicals or solvents, ensuring patients are treated with pure cannabinoid therapeutic compounds of the highest quality.

Company Details

Registered Office: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216

Postal Address: CRV Building, Level 2, Waikato Innovation Park, 2 Melody Lane, Hamilton East, Hamilton, 3216

Telephone: +64-7-949-8393

Facsimile: n/a

Website: https://cannasouth.co.nz/

First Listed: 19/06/2019

Balance Date: 31 December

AGM: 30/06/2023

Directors and Executives

Colin Foster

CFO / Company Secretary

Anthony Ho

Independent Chairman

Mark Lucas

Chief Executive Officer

Christine Pears

Independent Non-Executive Director

Mark Scapens

Non-Executive Director

Announcements

Title	Date	Type
Cannasouth Announces Termination of Employment of COO	Mon, Apr 15 2024 04:08 pm	ADMIN
Cannasouth Announces CEO Resignation	Thu, Apr 11 2024 10:23 am	ADMIN
CBD – Suspension of trading of Securities	Thu, Mar 28 2024 05:39 pm	HALT
Cannasouth Announces CFO Resignation	Thu, Mar 28 2024 05:06 pm	ADMIN
Appointment of Voluntary Administrators	Thu, Mar 28 2024 05:03 pm	RA
Cannasouth Limited (“CBD”) - Trading Halt Extension	Thu, Mar 28 2024 08:45 am	HALT
Cannasouth Limited — Trading Halt of Securities	Tue, Mar 26 2024 09:59 am	HALT
Change of Merger Accounting Policy	Fri, Mar 22 2024 03:56 pm	ANNREP
Preliminary Results for the Year Ended 31 December 2023	Thu, Feb 29 2024 05:23 pm	FLLYR
Resignation of RestoreMe Clinic Ltd CEO	Wed, Feb 14 2024 10:50 am	ADMIN

Major Holdings Announcements

Date	Name	No. Held	%	Current
15/08/23	Nicholas Jon Foreman	23,605,360	17.61	7.36
26/06/23	Mark James Scapens	23,887,591	-	7.45
08/06/23	Mark Lucas	28,029,435	27.60	8.74
11/03/20	Adam Sorensen	5,165,563	6.14	4.89

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
13/02/24	Anthony Ho	2,700,000	-	-	-
19/12/23	Christine Pears	210,000	-	-	-
22/06/23	Gregory Misson	1,136,067	-	-	-
08/06/23	Hilary Webber.	2,710,425	-	-	-
15/09/22	Juliet Hull	28,766	-	-	-
10/08/21	Colin Foster	250,000	-	-	-
23/10/20	Conor English	4,741	-	-	-

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 13/02/2024